While traditionally men have had limited options in contraception, the findings presented at the conference, sponsored by the National Institutes of Health, suggest that may change in the near future. Researchers from Columbia University, the University of Washington, and Shepherd Medical Company presented a variety of methods, each with encouraging findings.
Columbia researchers offered a drug that uses vitamin A's role in fertility as a means of contraception. Avoiding vitamin A alone would cause men to lose fertility, but it also causes illness. Luckily, Dr. Debra Wolgemoth and her team discovered a previously abandoned drug that interferes with vitamin A receptors in the testes. This feature, which caused a pharmaceutical company to shun the drug initially, makes it effective in the fight against fertility.
Lab tests in mice were successful and caused no harmful side effects. Based on this data and earlier findings, Dr. Wolgemoth expressed confidence in the future of the drug. "The testis is extremely sensitive to the drug," she said. "We're optimistic that there would be no adverse side effects in humans as well."
The method presented by University of Washington researchers also took advantage of existing drugs to provide a new solution. Their efforts combined a shot of DepoProvera, a female contraceptive, with a topical testosterone gel. Experiment participants were given a shot every three months and rubbed on the gel daily. The results were quite impressive, as sperm was knocked out effectively in 90 percent of the men. However, the inconvenience of the treatment may harm its viability.
Researchers from Shepherd Medical Company offered a drug free method that is a sort of reversible vasectomy. In this method, a set of plugs dubbed the "Intra Vas Device" or "IVD" blocks sperm from flowing through the vas deferens. The advantage here is that fertility can be easily restored by removing the plugs. The company's findings were encouraging as well: 92 percent of the men tested had little to no sperm after a six month period. The reversibility and effectiveness of the IVD suggest a promising future.
"We could have something like the IVD on the market in four to five years if we make an all-out effort with funding and focus," said Elaine Lissner, director of the Male Contraception Information Project. She sees the flaws of current contraceptive methods as keys to future success.
"Vasectomy is permanent, and condoms are not foolproof. A reversible, reliable long-term method would meet a big need."
The need is bigger than many realize. According to the National Campaign to Prevent Teen Pregnancy, nearly one-third of the 6.4 million pregnancies in the United States were unwanted. Approximately 1.3 million of these ended in abortion. Lissner acknowledged that reliable male contraception could have a dramatic effect in other countries as well.
"In wealthier countries, a new contraceptive would improve the quality of life," she said. "But in developing countries, an affordable, reliable contraceptive would actually save lives."
The exact number of lives that could be saved is unclear, but it is undoubtedly substantial. In Ethiopia, one in 14 pregnancies results in maternal death. And according to a study by UNICEF and the World Health Organization, even women in South-central Asia face a one in 46 lifetime risk of maternal death.
With such a dire need for reliable contraceptives, the only thing remaining, said Lissner, is encouragement.
"Pharmaceutical companies have no incentive to develop a cheap long-lasting method, and we can't expect them to take the lead. Men will get one if, and only if, they demand it of their governments."
SOURCES:
"Of mice and men: new male contraceptives successful in rodents and humans," Male Contraception Information Project"One-third of pregnancies in the United States are unwanted," Women's Health News
"Maternal Mortality in 2000: Estimates developed by WHO, UNICEF, UNPA," World Health Organization
Mark Lacey, "For Africa's Poor, Pregnancy Is Often Life Threatening," The New York Times
Press Resources, Male Contraception Information Project
Published by Brian Willett
Brian Willett is a graduate of UNC-Chapel Hill and earned his Bachelor's in journalism with a specialization in public relations. He is also an ACE-Certified Personal Trainer. His interests include reading,... View profile
- Coping with the Side Effects of Advair This article discusses the potential side effects of Advair. I use my personal experience with this drug to explain ways to alleviate some of the symptoms and I also discuss which symptoms of Advair should be conside...
- Advair Side Effects: Tips for Coping with the Side Effects of Advair Advair is a steroid inhaler prescribed to people suffering from asthma and COPD; this medication claims to prevent asthma attacks, but has a long list of side effects. This is how to recognize and deal with some of th...
- Fen-Phen Side Effects: Xerostomia (a.k.a. Dry Mouth or Cotton Mouth) Taken off shelves in 1997, the popular diet drug known as Fen-Phen caused a number of side effects, including a decrease in the salivary flow.
- Cialis: Side Effects and Cautions Cialis treats erectile dysfunction (impotence). Because the drug works by lowering blood pressure, it is not suitable for all men. Rare but serious, and sometimes permanent, side effects cannot be ignored. A talk with...
- Fosamax Side Effects Fosamax has numerous side effects on the digestive system and produces relatively little new bone.
- Male Contraceptives - Current Research
- National College Football Signing Day 2009: University of Washington Huskies
- University of Washington Uses New Method to Track Obesity
- University of Washington Hires Steve Sarkisian as Head Coach
- The University of Washington Tacoma's Unveils Tahoma West Literary and Arts Magazine
- University of Phoenix MBA Course Project Plan Paper
- Hormone Replacement Therapy (HRT) Side Effects Include Brain Shrinkage
|
|